Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CytomX Therapeutics Inc.

    NASDAQ: CTMX · Real-Time Price · USD
    2.30
    0.17 (7.98%)
    At close: May 13, 2025, 10:14 AM

    CytomX Therapeutics Revenue

    CytomX Therapeutics reported an annual revenue of $138.1M, reflecting a 36.45% growth. For the quarter ending December 31, 2024, CytomX Therapeutics generated $38.09M in revenue.
    Revenue (ttm)
    $138.1M
    Revenue Growth
    36.45%
    Price / Sales Ratio
    0.63
    Revenue / Employee
    $1.16M
    Employees
    119
    Market Cap
    185.03M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist